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AIDS Acquired Immuno-deficiency Syndrome  
ANC Antenatal Care 
STI Sexually Transmitted Infections 
WHO World Health Organization 
OTH Omdurman Teaching Hospital 
PCH Police Central Hospital 
RPR Rapid Plasma Reagin 
TPHA Treponema Pallidum Haemoagglutination
HVS High vaginal swab 
NS Not significant 
HIV Human immuno-deficiency virus 
GTT Germ Tube Test 
UNDP United Nations Development Programme 
LGV  Lymph granuloma venereum  
PID Pelvic inflammatory disease  
PCK  Polymerase Chain Reaction   
VDRL  Venereal Disease Research Laboratories 
ELISA Enzyme Linked Immunosorbent assays  
 
  
   
 
ABSTRACT 
This is cross-sectional study conducted at Police Central 
Hospital and Omdurman Teaching Hospital, Gynaecological 
Clinics, between Aug.1999 to Feb. 2000 to determine the 
prevalence of common STI and candida. It involved 110 patients 
attending these clinics.  
The study was conducted by direct interview, medical 
examinations and laboratory investigations. 
High STI prevalence was detected (38.2%) while the 
prevalence of more than one STI is 4.5%.  
The most prevalent organism was Candida albicans 
(19.1%), followed by Chlamydia trachomatis (9.1%), 
Trichomoniasis (6.4%), confirmed syphilis (5.4%), gonococcal 
infection (1.8%) and HIV (1.8%). 
Neither vaginal discharge nor its colour is found to be 
sensitive or specific for the diagnosis of STI. 
The presence of genital ulcer, copious vaginal discharge 
and occupation of the husband are not good predictors for STIs. 
Recommendations are to assess all patients with vaginal 
discharge for STI, to adopt a national strategy for prevention of 
STI/HIV and early treatment of STI were suggested. 
This study is the other arm of another study done by          
Dr. Ortashi who investigated the prevalence of STI in pregnant 
women attending the antenatal care clinics during the same period 
of time.  
 
 
  
   
 
  ﻤﻠﺨﺹ ﺍﻷﻁﺭﻭﺤﺔ
ﺔ ﺍﻟﻤﺭﻜـﺯﻱ، ﻫﺫﻩ ﺩﺭﺍﺴﺔ ﻤﻘﻁﻌﻴﺔ ﺘﻤﺕ ﻓﻲ ﻋﻴﺎﺩﺓ ﺃﻤﺭﺍﺽ ﺍﻟﻨﺴﺎﺀ ﺒﻤﺴﺘﺸﻔﻰ ﺍﻟـﺸﺭﻁ 
 ﻟﺘﺤﺩﻴـﺩ 0002 ﻭﺤﺘﻰ ﻓﺒﺭﺍﻴـﺭ 9991ﻭﻤﺴﺘﺸﻔﻰ ﺃﻡ ﺩﺭﻤﺎﻥ ﺍﻟﺘﻌﻠﻴﻤﻲ ﻓﻲ ﺍﻟﻔﺘﺭﺓ ﻤﻥ ﺃﻏﺴﻁﺱ 
ﻭﻗـﺩ ﺸـﻤﻠﺕ . ﺃﺴﺒﺎﺏ ﻭﻨﺴﺒﺔ ﺍﻷﻤﺭﺍﺽ ﺍﻟﻤﻨﻘﻭﻟﺔ ﺠﻨﺴﻴﺎﹰ ﺒﻴﻥ ﺍﻟﻤﺘﺭﺩﺩﺍﺕ ﻋﻠﻰ ﻫـﺎﺘﻴﻥ ﺍﻟﻌﻴـﺎﺩﺘﻴﻥ 
  . ﺍﻤﺭﺃﺓ011ﺍﻟﺩﺭﺍﺴﺔ 
ﺘﻤﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺒﻤﻘﺎﺒﻠﺔ ﻤﺒﺎﺸﺭﺓ ﻟﻠﺴﻴﺩﺍﺕ ﻭﻤلﺀ ﺍﺴﺘﺒﻴﺎﻥ ﺜﻡ ﻋﻤل ﻜﺸﻑ ﻁﺒﻲ ﻤﺼﺤﻭﺏ 
ﻭﺠﺩ ﺃﻥ ﻫﻨﺎﻟﻙ ﻨﺴﺒﺔ ﻋﺎﻟﻴﺔ ﻤﻥ ﺍﻟﻨﺴﺎﺀ ﻴﺤﻤﻠﻥ ﺃﺤﺩ ﻫﺫﻩ ﺍﻷﻤﺭﺍﺽ ﺍﻟﻤﻨﻘﻭﻟﺔ . ﻔﺤﻭﺼﺎﺕ ﺍﻟﻤﻌﻤﻠﻴﺔ ﺒﺎﻟ
  %.2.83ﺠﻨﺴﻴﺎﹰ 
ﻴﻠﻴﻪ ﻤﻴﻜﺭﻭﺏ % 1.91ﺍﻜﺜﺭ ﺃﻤﺭﺍﺽ ﺍﻻﻟﺘﻬﺎﺒﺎﺕ ﺍﻟﻤﻨﻘﻭﻟﺔ ﺠﻨﺴﻴﺎﹸ ﻜﺎﻥ ﻓﻁﺭ ﺍﻟﻤﺒﻴﻀﺎﺕ 
% 8.1ﻓﺎﻟـﺴﻴﻼﻥ % 4.5ﺜﻡ ﺍﻟﺯﻫـﺭﻱ % 4.6ﺜﻡ ﻁﻔﻴل ﺍﻟﻤﺸﻌﺭﺓ ﺍﻟﻤﻬﺒﻠﻴﺔ % 9.1ﺍﻟﻤﺘﺩﺜﺭﺓ  
  %.8.1ﺎﻋﺔ ﺍﻟﻤﻜﺘﺴﺒﺔ ﻭﻤﺭﺽ ﻋﻭﺯ ﺍﻟﻤﻨ
ﻟﻡ ﺘﻭﺠﺩ ﻋﻼﻗﺔ ﺘﺸﺨﻴﺼﻪ ﺒﻴﻥ ﺇﻓﺭﺍﺯ ﺍﻟﻤﻬﺒل ﻭﻻ ﻟﻭﻥ ﺍﻹﻓﺭﺍﺯ ﻤﻊ ﺍﻷﻤﺭﺍﺽ ﺍﻟﻤﻨﻘﻭﻟـﺔ 
ﻜﻤﺎ ﻟﻡ ﻨﺠﺩ ﺃﻯ ﻤﺅﺸﺭﺍﺕ ﺇﻴﺠﺎﺒﻴﺔ ﺍﻟﺩﻻﻟﺔ ﺒﻴﻥ ﻤﻬﻨﺔ ﺍﻟﺯﻭﺝ ﻭﻭﺠﻭﺩ ﺃﻯ ﺃﻤـﺭﺍﺽ ﻤﻨﻘﻭﻟـﺔ . ﺠﻨﺴﻴﺎﹰ
  . ﺠﻨﺴﻴﺎﹰ
ﺘﻤﺜﻠﺕ ﺍﻟﺘﻭﺼﻴﺎﺕ ﺍﻟﻤﻘﺘﺭﺤﺔ ﻓﻲ ﻋﻤل  ﻓﺤﻭﺼﺎﺕ ﻟﺠﻤﻴﻊ ﺍﻟﻤﺭﻴﻀﺎﺕ ﺍﻟﻼﺌﻰ ﻴـﺸﺘﻜﻴﻥ 
ﻓﺭﺍﺯﺍﺕ ﻤﻬﺒﻴﻠﺔ ﺤﺘﻰ ﻴﺘﻡ ﺍﻟﻭﺼﻭل ﻟﻠﺴﺒﺏ، ﻜﻤﺎ ﺩﻋﺕ ﺍﻟﺘﻭﺼﻴﺎﺕ ﺇﻟﻰ ﺘﺒﻨﻰ ﺴﻴﺎﺴـﺔ ﻗﻭﻤﻴـﺔ ﻤﻥ ﺇ 
  .ﻟﻠﻤﻜﺎﻓﺤﺔ ﻭﺍﻟﻌﻼﺝ ﺍﻟﻤﺒﻜﺭ ﻟﺠﻤﻴﻊ ﺍﻷﻤﺭﺍﺽ ﺍﻟﻤﻨﻘﻭﻟﺔ ﺠﻨﺴﻴﺎﹰ
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INTRODUCTION 
Sexually transmitted diseases have been a much-neglected 
area in public health in most of the developing world, despite 
overwhelming evidence of their impact on health particularly of 
women in the reproductive age. 
Historically data from medical texts revealed the existence 
of gonorrhea and chancre in Japan during the 15th century. 
A subsequent increase in the number of STI infected 
individuals was noted during World War II. This historical 
perspective evaluation gives us a clue to the relation between STI 
prevalence and the influence of social, economic, political and 
cultural factor.(1) The emergence of AIDS in the 1980s has 
highlighted the importance of sexual transmission in the spread of 
infection and the lack of control programs for   STI. 
      Social, economic and political disruptions often involve 
sudden migration of population and increased sex workers. 
Therefore, Africa is the worst affected by AIDS especially the 
countries, which surround the Sudan. In fact infection rates are 
reaching alarming new highs in many of these countries.  
Therefore assessment of the prevalence of HIV /STI 
remains an important public health priority.  
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LITERATURE REVIEW 
STI infect the reproductive tract as their primary site, with 
transmission occurring during sexual intercourse or from mother to 
child during pregnancy and child birth.  
On the other-hand the spread of HIV may be due to blood 
transfusion, injections of therapeutic purposes, drug abuse and 
infection with other STI which may serve as co-factors for HIV 
transmission. 
More than thirty bacterial, viral and parasitic diseases have 
now been identified that can be transmitted sexually.  There are 
estimated 250million new cases of STI annually. (2)   
In sub-Saharan Africa HIV and AIDS continue to have 
devastating impact where they account for 108 million deaths in 
1998.(3)   
Estimates of the impact show that HIV/AIDS will have a 
significant effect on future population size and age structure. 
Moreover, this may lead to a decrease in labor force participation 
rate. A major concern is the loss of skilled personnel. With two-thirds 
of all the people worldwide who are infected with HIV, Africa remains 
the most seriously affected region; 70.4% of adults in Africa are 
infected with HIV.(4) 
  3 
The transmission of HIV through heterosexual and 
homosexual intercourse accounts for about 86% of all HIV/AIDS 
cases worldwide.(5) 
The WHO estimates, although based on comprehensive 
survey of the available information, are limited by the quantity and 
quality of the prevalence data available from different regions and 
our knowledge of the duration of the infection. A wide spread 
difference between regions in the incidence of AIDS has been 
associated with socioeconomic and cultural differences. (6) 
Data from epidemiological surveys show that within a 
country and between countries in the same region, the prevalence 
and incidence of STI may vary widely even in similar population 
groups. In some parts of the world with high prevalence countries, 
prevalence rates in the population at risk “15-49 year olds” are up to 
2%; while low prevalence countries have rates of < 0.1 %.( 7)  
By 1996, an estimated 1.7% million Ethiopians were HIV 
infected, HIV prevalence is projected to reach 6% by 2004. (8)  
In 1993 World Development Report estimates suggested 
that in demographically developing countries STI “excluding HIV” 
account for 8.9% of the disease burden in women age 15-45 years 
and 1.5% in men in the same age group. This ranked STI “excluding 
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HIV” as the second major cause of lost disability-adjusted life years 
in women of reproductive age.(9)  
Even in the developed countries, the prevalence of HIV is 
still high. HIV infection was the 7th leading cause of death among 
people aged 15-24yrs in the US during 1997.(10)  
The disease burden from STI is a result of complications 
and sequel that may follow infection, e.g. primary infection with 
gonorrhea and chlamydia in woman is usually symptom-less when 
left untreated. However, infection may migrate upwards from the 
lower reproductive tract and leads to pelvic inflammatory disease 
(PID), chronic pelvic pain, tubo-ovarian abscesses, ectopic 
pregnancies and infertility. In addition, untreated infection in 
pregnant women may result in fetal loss, still birth, low birth weight 
and eye and lung damage in the newborn. 
According to the results of study done in Zimbabwe, about 
28% of infants of HIV- positive mothers are infected in utero (20% 
during labour) and an additional 14% are infected by breast 
feeding.(11)  
The African Journal of Reproductive Heath reported that 20-
30% of couples in Africa had considerable primary and secondary 
infertility. The increased incidence of infertility in Africa is evidently 
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due to high prevalence of classic (STI) complications connected with 
unsafe abortions and postpartum infections.(12) 
According to the Family Planning Perspectives Journal, HIV 
infected women have a higher incidence and prevalence rate of 
gynecological disorders compared with the uninfected women. (13)  
The HIV/AIDS epidemic in sub-Saharan Africa is spread 
mainly through heterosexual intercourse. In fact the prevalence of 
HIV-1 infection is thus higher among women undergoing induced 
abortions than among those who deliver and higher among women 
who refuse testing than among those who consent. (14)  
Worldwide, HIV studies estimated that over 47 millions 
people have been infected of whom 14 million have died. (15)  In 
Sudan, few studies investigated the prevalence of STI . A study 
published in the AIDS Analysis African Journal estimated HIV 
prevalence in Sudan to be 0.6%. It reported 150000 infected 
patient.(16)  
UNDP News Journal had a special report on STI project for 
North and South Sudan. It declares that HIV transmission has 
increased due to a high concentration of military personnel and 
population displacement. It suggests that the south have the highest 
HIV prevalence and 46% of known AIDS cases. STI increased from 
2.3% in 1989 to 14.1%in 1994. (17)  
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 Ortashi, who conducted the other arm of this study on 151 
pregnant ladies, non of them was HIV positive, found the most 
prevalent organism was Chlamydia trichomatis 19.9%, followed by 
Candida 13.9%, Trichomonas vaginalis 7.3%, confirmed syphilis  
2.6%  and   N.  gonorrhea 2.0 %.( 18)  
Elhaj and ELNaeim in 1996 studied 200 non pregnant 
ladies, they found Chlamydia to be prevalent in only 2.3%, 
Trichomonas vaginalis in 3.2% and N. gonorrhea in 0.6 %.( 19)  
Omer in 1977(20) studied 400 non-pregnant females with 
vaginal discharge; he found Candida albican prevalent in 25.4% of 
those with vaginal discharge. In another study carried out by 
Elnaeim and Omer in 1994(21) they found evidence of trichomoniasis 
in 17.4% of patients with vaginal discharge. 
Aetiology: 
The conditions, which are considered in this study, include 
gonorrhea, chlamydial infection, Trichomonas vaginalis, Candida, 
syphlilis, and HIV. Other conditions, which may be transmitted by 
sexual contact, include genital warts, herpes genitals, chancroid and 
hepatitis A and B. 
Gonorrhea: 
This is caused by infection with Neisseria gonorrhea, which 
infects only human beings. It is a Gram negative dipplococci. It is 
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often intracellular. Gonorrhea remains a common cause of morbidity 
in women and neonates worldwide. The organism is highly 
infectious and is transmissible prior to the onset of symptoms. 
Gonorrhea has a short incubation period usually 2-5 days. 
Asymptomatic infections are common in women especially during 
pregnancy and also occur in men. This results in late presentation 
with complications, and facilitates disease transmission. A site for 
local complications includes skenitis and bartholinitis. Pelvic 
inflammatory diseases occur in about 15% of infected women. 
Distant complications consist of perihepatitis and septicaemia. 
Gonorrhea may be associated with early abortion, intrauterine 
growth restriction and postpartum infection.   
 Also it is implicated in the aetiology of infertility and ectopic 
pregnancy. In men it can cause urethritis, epididymitis, prostatitis 
and disseminated infection. Gonococcal ophthalmia neonatorum is a 
recognized complication. 
Chlamydia trachomatis: 
This is an unusual Gram-negative bacterium, which behaves 
like a virus in that it replicates intra-cellularly. It is responsible for at 
least half of all cases of non-specific genital infection, which includes 
non-specific urethritis in the males and related conditions in the 
females. It is an exclusively human pathogen which consists of sero-
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viruses most of which are associated with infections like trachoma, 
genital tract infections, conjunctivitis, infant pneumonia and lymph 
granuloma venereum (LGV). 
Chlamydia also causes urethral syndrome in young women, 
cervicitis, PID, perihepatitis and acute appendicitis. Late sequel of 
PID is infertility and ectopic pregnancy. 
Chlamydia is also a common cause of neonatal disasters. A 
congenital infection accompanied by nasopharyngeal infection may 
later progress to a febrile pneumonitis and otitis media. 
Chlamydia can be demonstrated in cell culture for which a 
special transport medium and prompt delivery to the laboratory are 
necessary. Detection of chlamydial DNA using nucleic acid 
hybridization and polymerase chain reaction (PCR) is very sensitive 
but is at present unsuitable for routine diagnosis 
 Trichomoniasis:  
This is caused by infection with the protozoon Trichomonas 
vaginalis, which is actively motile by virtue of its four unipolar 
flagellae. The condition is usually sexually transmitted. Although 
non-sexual transmission is theoretically possible, it is likely to be an 
exceptional means of acquisition. Trichomoniasis is frequently 
associated with other STI.  
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T. vaginalis is an ovoid, globular pear-shaped, flagellate,   
12-25 µm long. It adheres to mucous membranes. Squamous 
epithelial cells are involved. The conditions are typically presented 
with foul-smelling mucopurulent vaginal discharge. The discharge 
may be frothy grey to green yellow one. Accompanying symptoms of 
dysuria and vulval soreness may be present. 
The diagnosis is proved by the microscopic identification of 
the causative protozoa in a wet film. It can also readily be seen in 
cervical smear. Swabs sent in a transport media can also be 
cultured. 
Syphilis:   
Syphilis is one of four human treponemal diseases whose 
causative organisms are morphologically indistinguishable and 
which cannot be differentiated by the results of serological tests. 
Syphilis is a chronic systemic disorder caused by infection with 
Treponema pallidum. The other non- venereal treponematoses are 
yaws, pinta and endemic syphilis. Only their epidemiology, clinical 
manifestations and mode of transmission can differentiate them. 
T. pallidum is transmitted through direct contact with an 
infectious lesion of the mucous membranes or abraded skin. After 
an incubation period of 9-90 days the multiplication of the 
spirochetes gives rise to the primary chancre, which is a raised 
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round indurate painless ulcer. It is usually single, sited on the 
external genitalia and accompanied by bilateral non-tender rubbery 
inguinal lymphadenopathy. 
Treponema is detectable in specimen from these lesions 
using dark field or fluorescence microscopy. Serum antibodies can 
be detected 1-4 weeks after the chancre has formed. The untreated 
lesion will heal spontaneously within 3-8 weeks, which is usually 
followed by asymptomatic period of 6 weeks to 6 months. 
Secondary lesions occur in different organs and tissues of the body. 
These lesions are microscopically positive and all serological tests 
are reactive, secondary lesions heal spontaneously over a period of 
two months. An asymptomatic or latent period then follows. It can 
last for years, even a lifetime. 
The untreated patient may have persistent latent infection or 
may progress after several years to develop either tertiary 
gummatous syphilis, characterized by chronic inflammation of skin, 
bones, mucous membranes and viscera, or quaternary syphilis, 
typified by neurological and cardiovascular disease. 
T. pallidum can infect the fetus transplacentally leading to 
intrauterine death and midtrimester abortion. In surviving fetuses 
intrauterine growth restriction and prematurity are likely to occur. 
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Congenital syphilis may be evident at birth or not seen until the child 
is six months of age . 
Serological test for syphilis includes the Venereal Disease 
Research Laboratories (VDRL) which is non specific. Highly 
sensitive specific treponemal antibody tests include the absorbed 
fluorescent treponemal antibody test and the Treponema pallidum 
haemagglutination (TPHA) test.  
These tests may remain positive for many years, even after 
the disease has been effectively treated.  
Candidiasis:  
Vulvovaginal candidiasis occurs worldwide. About 75% of 
women will experience an episode at sometime, usually in relation to 
pregnancy or following antibiotic therapy. Other predisposing factors 
include the intake of some high dose oestrogen, contraceptive pills 
and glycosuria.  
It is a fungal infection with Candida albicans. Other candida 
spp such as C.glabrata account for less than 10% of cases, but may 
be more resistant to treatment.  
Although sexual acquisition probably plays only a small role 
in the aetiology of Vulvovaginal candidiasis, the infection can be 
passed to male partners, who may act as asymptomatic reservoirs 
of reinfection or may develop symptomatic balanitis. 
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C. albicans is an opportunistic pathogen which requires an 
underlying deficit in host local or systemic immunity in order to 
invade the vagina and cause disease.  
Vulvovaginal candidiasis is a well-recognized complication 
of the reduced cellular immunity in late pregnancy and in all 
pathological states associated with immunosuppression including 
HIV.  
Classical symptoms and signs include vaginal itching, 
odour-less curdy white discharge “cottage cheese”, dysparunia and 
erythema of the labia and vulva. The diagnosis should be confirmed 
and other pathogens excluded by thorough microbiological 
investigation. 
 Positive direct microscopy has a very high diagnostic value. 
Gram staining could show the Gram-positive mycelia of the fungus. 
Culture remains the most sensitive method currently 
available for the detection of the candida. It will give a positive result 
in carriers as well as from women with symptomatic vulvo-vaginal 
candidiasis. 
Therefore, culture is only recommended if vaginal 
candidiasis is clinically suspected but that wet mount microscopy is 
negative. 
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Bacterial vaginosis:   
It is one of the commonest causes of abnormal vaginal 
discharge. It is a complex condition in which a polymicrobial vaginal 
flora replaces the normal predominant lactobcilli. 
The bacteria involved include Gardenerella vaginalis, 
Bacterides species, Mycoplasma hominis and Mobiluncus species. 
Their metabolism produces biologically active metabolites, including 
volatile amines, which cause the characteristic fishy smell of the 
condition. This is associated with a thin grey or white vaginal 
discharge that is sometimes frothy. Many women with bacterial 
vaginosis are asymptomatic. 
Clinical diagnosis of bacterial vaginosis can usually be 
confirmed by simple tests on the vaginal discharge. 
Typically the pH is greater than 4.5. Microscopy of a wet film 
shows active motility of Mobilincus spp., and masses of small 
bacteria coating epithelial cells “clue cells”. The bacteria are Gram-
negative. Culture can be misleading. 
Newer methods of diagnosis are mainly used for research 
purposes at present.(22)   
Human immunodeficiency virus:  
The human immunodeficiency virus (HIV), which is the 
causative agent of acquired immunodeficiency syndrome (AIDS) is 
  14 
transmitted between humans mainly by sexual contact. Other routes 
of transmission are: peri-anal, from an infected mother to her child, 
by transfusion of infected blood and through exposure to 
contaminated needles or other skin piercing objects. Two types of 
HIV have been recognized, HIV-1 and HIV-2. 
HIV belongs to the family retrovirdae. Retrovirus virions are 
spherical, measure 80-130nm in diameter and have a three layered 
structure. 
The genome nucleocapsid complex consists of single 
stranded RNA molecules. Each virion is diploid so it contains two 
identical copies of its RNA genome; the genome has reverse 
transcriptase molecules. The RNA is surrounded by a capsid 
consisting of core proteins .An envelope derived from host cells 
surrounds the viral core. 
 
People infected with HIV usually develop antibodies to the 
virus within 1-4 months of infection (window period) i.e. the time for 
sero-conversion to be detected by the current available sero-
diagnosis assay. 
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The following methods are used for diagnosis or 
confirmatory procedure: 
1- Serological screening procedures:  
• Enzyme linked immunosorbent assays (ELISA). 
• Agglutination assays. 
• Immunodot assays . 
2- Serological supplement tests:-   
• Western blot. 
• Indirect immunofluorescence. 
• Radio immunoprecipitation. 
• Line immunoassay. 
Sensitivity and specificity are two major factors that 
determine the accuracy of a test in distinguishing between infected 
and uninfected persons. A test with high specificity will have few 
false positive results, and should be used when there is a need to 
minimize the rate of false positive results. “E.g. for the diagnosis of 
HIV infection in an individual” Although the sensitivity and specificity 
of individual tests may vary, both should meet minimum standards 
(99% and 95% respectively). (23) 
 
There are three main objectives for which HIV 
autoantibodies testing is performed: -  
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i- Transfusion, transplant or donation safety. 
ii- Surveillance e.g. for the purpose of monitoring the prevalence of 
HIV infection overtime in given population. 
iii- Diagnosis of HIV infection: voluntary testing of serum from 
asymptomatic persons or from persons with clinical signs and 
symptoms suggestive of infection or AIDS. 
The prevalence of STIs: 
  Women at the reproductive age represent a sector of the 
community who is sexually active and hence are prone to STIs. 
Many studies around the world have tried to assess the 
prevalence of STI with different result due to several factors. 
Wong M.L and his colleagues in Singapore compare the 
prevalence of STIs between freelance and brothel-based sex 
workers. They found that the two most common STIs in both groups 
were chlamydial cervicitis and syphilis. (24)  
A survey on the STI in the rural region of Chatlon conducted 
by Tajikistan Republican Reproductive Health center investigated 
1034 women, among these women 75.7% of the examined cases 
revealed a variety of STI.  trichomoniasis  25.3%, candidiasis 17.9% 
chlamydia trachomatis 14.9%, syphilis 5.6 % and gonorrhea  0.2 % . 
STI were most commonly found in the 21-39 age group. 
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Furthermore, STI screening of the 19-20 age group revealed that 
77.7 % had vaginal discharge.(25) 
A clinical trial was conducted to determine the prevalence of 
Neisseria gonorrhea and other STI causing organisms. This study 
was done by Divekar et al., in Mumbai, India, who investigated 336 
female attending STIs clinic. The study showed that 9.7 % of the 
women were gonorrhoea –positive, 23.3% were chlamydia-positive 
and 5.9% were trichomonas-positive. Moreover, HIV was more 
prevalent among female sex workers (p<0.001). The author 
concluded that gonococcal infection is significantly associated with 
HIV .An important correlation between sex behaviour and the 
prevalence of gonorrhea, trichomoniasis and HIV was found. (26)   
Dada A.J. and his colleagues in Logos, Nigeria, had 
undergone a serosurvey of syphilis and human immunodeficiency 
virus antibodies among 796 females. The sero-prevalence rates 
were 4% for rapid plasma reagin (RPR) and TPHA assay confirmed 
syphilis, 12 % for HIV –1, and 2 % for HIV – 2.(27)  
 Ramon R. and his colleagues tried to assess the 
prevalence of HIV in women of childbearing age in Abidjan, cote de 
lvoire. In this study HIV testing was systemically offered to a total of 
1482 non-pregnant women 20-50 years of age attending two 
gynecological clinics. The prevalence of HIV infection in this sample 
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was 21.3%.(28)In fact Cote de  lvoire has one of the highest HIV 
prevalence rates in west Africa.(29)  
Paris M and his colleagues conducted a study about the 
prevalence of gonococcal and chlamydial infection among 
commercial sex workers in lquitos, peru, which revealed that 22% of 
these females were positive for chlamydia and 14% positive for 
gonorrhea. These high infection rates were attributed to the lack of 
knowledge regarding HIV and STI in addition to the high-risk 
behavior among this population.(30)  
The prevalence of STI and the frequency of genitourinary 
symptoms and signs were assessed in 1233 females aged 18-45 
years, of mean age 26, in Yasunde and Douala, Cameroon. 
 Rayan KA and his colleagues conducted this study. They 
found that 11% had gonorrhea, 12% had chlamydia, 3% had both. 
20% had a positive wet mount for trichomoniasis. 65% reported 
abnormal vaginal discharge and 44.7% reported pelvic pain. Clinical 
diagnosis for cervicitis and trichomoniasis in this study had 
sensitivity of less than 50% and specificity of greater than 65%. 
They concluded that: clinical diagnosis was not an accurate 
predictor of infection at the individuals level.(31)  
Ramjee and his colleagues conducted a study to assess the 
prevalence of STI, including HIV, among 145 female prostitutes 
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working at truck stops in the Kwazulu- natal midlands of South 
Africa. The examinations found that 50.3% of the women were HIV 
positive, 41.3% were infected with Trichomonas vaginalis, 40.6% 
had Candida albicans, 14.3% had Neisseria gonorrhoeae, 16.4% 
had Chlamydia trachomatis, 71% had bacterial vaginosis and 42.1% 
had active syphilis.(32)  
A randomized, community trial of intensive STI control for 
AIDS prevention was conducted by Wawer MJ and his colleagues in 
Rakai, Uganda. They investigated 56 communities, which are 
grouped into 10 clusters. 16.9% of the subjects were HIV-positive, 
10.0% had syphilis, 23.8% of women had trichomoniasis, and 50.9% 
had bacterial vaginosis. They suggested that detailed STI 
assessment expected to document the relationship between STI 
control and HIV. Moreover, it will identify which STI confer the 
greatest population attributable risk for HIV transmission, facilitating 
targeted control efforts in the future.(33)  
Sarkar S and his colleagues conducted a study to assess 
the prevalence of HIV antibody and selected STI in a resident 
population of 593 brothel-based female prostitutes in a business 
town 100km from Dhaka, Bangladesh. No HIV antibody was found 
in any of the blood samples. 57.1% women, however, has evidence 
of either past or present infection of syphilis as measured by TPHA 
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testing, 6.8% were VDRL-positive at a more that 1:8 dilution, and 
28% were infected with either gonorrhea or chlamydia. This high 
prevalence of gonorrhea or chlamydia and TPHA detected in this 
study suggest that HIV infection would spread rapidly if introduced in 
this population, and later expulsion into the population.(34)  
A cross-sectional study conducted in Burkina Faso’s two 
largest cities(35) (Ouagadougou and Bobo-Dioulasso) in 1994 
investigated the prevalence of HIV infection and other STI among 
426 female sex workers. The overall HIV prevalence was 58.2% and 
52.6% had at least one STI: primarily trichomoniasis 23%, syphilis 
15%, and gonorrhea 13%. The study identified the following 
significant, Independent risk factors for HIV infection. 
i- Two or more pregnancies. 
ii- Low perception of personal risk of HIV. 
iii- Syphilis. 
iv- The presence of genital warts.  
A cross-sectional study conducted in five locations in 
Cambodia in 1996 compared the prevalence of HIV and other STI in 
34 women seeking reproductive health services, 322 police and 
military personnel, and 437 brothel- based sex works. Among sex 
workers 38.7% had chlamydial and/or gonococcal infection and 
13.8% were syphilis seroreactive. Among police and military 
  21 
personnel, 2.1% had chlamydial infection, 5.0% had gonorrhoea and 
6.6% were syphilis sero-positive. 5.3% of the reproductive health 
care clients had chlamydial and/or gonococcal infection and 4.0% 
were syphilis sero-positive. HIV prevalence was 40.6% among sex 
worker, 12.5% among police and military personnel, and 4.5% in the 
reproductive health client group.(36)   
Gyanaecological conditions associated with HIV infection 
were examined in 481 regular female sex partners of HIV-positive 
male blood donors in a study of heterosexual HIV transmission 
conducted at Chiang Mai University Hospital in Thailand in 1992-
1996. Of these women 46.6% were HIV infected. A history of STI 
was more common among the HIV-infected women 31.7%. HIV-
infected women also were more likely to have abnormal vaginal 
discharge and cervical dysplasia (confidence intervals were 1.6%-
4.2 and 2.0-15.2 respectively). Among HIV positive women, the 
prevalence of abnormal vaginal discharge and bacterial vaginosis 
increased significantly with decreasing CD4 count. Syphilis, 
gonorrhea, chlamydia and trichomoniasis rate generally low and did 
not differ by HIV status.(37)  
A multi-center prevalence survey was conducted by Mother 
care Indonesia to examine the presence and magnitude of a 
reproductive tract infection/ STI problem. A total of 344 married 
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women aged 18-45 was enrolled as study sample. 23% were found 
to be positive for at least one STI. About 44% tested positive for 
candidiasis, 12.6% tested positive for more than one STI, 4.3% 
tested positive for gonorrhea, 7.7% tested positive for chlamydia. 
None of the women tested positive for syphilis.(38)  
Meda N. and his colleagues in the gynaecology and 
Obstetrics Department at the National Central Hospital Souro Sanou 
in Burkina Faso conducted a study to determine the prevalence of 
STI and HIV among 220 non-pregnant women of reproductive 
age.(39) They found that 77% had one STI. The most common STI 
were Trichomonas vaginalis 28% and Chlamydia trachomatis 27%. 
42% were HIV positive. HIV positive women were significantly more 
likely than HIV- negative women to be infected with Neisseria 
gonorrhea (30.4% vs 24.2%, P= 0.03). They concluded that women 
with genital infections are a group at high risk of HIV and other STI 
and a target population for preventive interventions. 
A seroprevalence survey conducted among 2240 individuals 
from Alexandria, Egypt confirmed assumptions of a low rate of HIV 
infection in Egypt. Reuganathan E. et al conducted this study. 
Overall, only 1.5% of the respondents were HIV seropositive by 
ELISA. The low rate of HIV prevalence is Egypt is presumed 
attributable to cultural factors as suggested by the authors.(40)             
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Management of STI:  
There is considerable evidence that infection with STI 
significantly increases one’s risk of contracting and transmitting 
HIV.(41) Therefore, improved STI treatment reduced HIV infection by 
40%, as proved by a study in a rural population in Tanzania.(42)  
In fact there are two approaches for management of STI: 
1- The etiological approach:  
Aetiological diagnosis is often regarded as the ideal 
approach in medicine. It enables service providers to make precise 
diagnosis and treat their patients with equal precision. In so many 
instances it can be very essential in helping our patients. However, it 
has some problems. First of all, it needs good laboratory equipments 
and skilled personnel which are not widely available in many of the 
developing countries.  
Infact, there are a large number of different bacteria, viruses 
and other pathogens that can be transmitted from one person to 
another during sexual intercourse. Therefore, to reach an 
aetiological diagnosis we may sometimes need sophisticated 
equipments.  
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Moreover, the range of existing laboratory test for STI is a 
little pit limited, and reaching an etiological diagnosis of most STI 
can be difficult, particularly in women e.g. both gonococcal and 
chlamydial infection in women currently have to be diagnosed 
through either culture techniques or antigen or genomic detection. 
However, both techniques are expensive.  
Lastly, even when there is access to reliable laboratory 
facilities, there are some delays in reporting test results and hence 
in treatment of STI cases. Delays in treatment can undermine the 
confidence a patient has in service providers. STI patients expect 
service providers to make a prompt and reasonably accurate 
diagnosis. They may also result in a significant proportion of clients 
refusing to attend for follow up.  
So, to summarize the etiological approach has some 
problems, nevertheless it has a place in treating patients of STI. 
2- Syndromic care management:  
A syndrome is simply a group of the symptoms a patient 
complains of, and signs discovered in examination. Syndromic case 
management as its name implies, depends on being able to identify 
and treat the syndrome caused by STI. In fact in many parts of 
Africa, no resources exist with which to properly diagnose STI. 
Therefore, the world Health Organization (WHO) promotes the 
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syndromic management of STI as an alternative approach to 
diagnosing and treating STI patients. The clinician who uses the 
syndromic approach bases his diagnosis and treatment upon 
syndromes; groups of clinical findings and patients symptoms, rather 
than the identification through expensive and time-consuming 
laboratory tests. (43)  
The symptoms and signs caused by different STI are similar 
enough to be easily recognized clinically. STI give rise to small 
number of clinical symptoms:  
1- Vaginal discharge in women.  
2-  Urethral discharge in men.  
3- Genital ulcers in both sexes.  
4- Swollen scrotum.  
5- Lower abdominal pain.  
6- Inguinal bubo swelling.  
7- Eye discharge in neonates.  
Treatment is offered for all diseases which could cause a 
given syndrome. Because the seven syndromes are easy to identify, 
it has been possible to use a clinical flowchart for each one. Health 
care personnel use this simple flowcharts which map out the steps 
needed to determine symptoms and treatment.(44)  
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Among the advantages of this approach are its cost-
effectiveness, simplicity and rapidity. Its limitations include a 
tendency toward over-treatment, poor performance in low-
prevalence areas and the neglect of asymptomatic patients.(45) 
Comprehensive STI care management include other factors 
such as.(46)  
- A viability of appropriate drug therapy.  
- Education on how to reduce the risk of re-infection.  
- Promotion of condoms.  
- Treatment of patient’s sexual contact.  
- Attendance for a follow up examination. 
Control and prevention of STI:  
STI interact uniquely with HIV infection, regardless of the 
form of sexual transmission of HIV. Both STI and HIV infections are 
behaviorally and biologically intertwined with one another. This 
concept is called epidemiologic synergy since they facilitate the 
sexual transmission of one another. Innovative and comprehensive 
STI control programs along with community and individual-based 
prevention programs should provide a more effective HIV control 
program by reducing the efficiency of HIV transmission in high risk 
individuals.(47)  
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The WHO recommended that effective STI control should 
continue to be a key component in HIV control efforts in areas where 
STI are prevalent.(48)  
This concept has been supplemented by virology studied 
showing that inter-current STI increases concentration of HIV in 
genital secretions,(49,50,51) but more importantly, it has been shown 
that improved clinical services for STI can significantly reduce the 
incidence of HIV in developing countries “the study of Tanzania”(42)    
There should be a certain policy and programs to control 
and prevent STI. Ten steps should be considered so as to organize 
an advocacy campaign. This ten steps are defining the issue, 
developing a strategy, refining the message, organizing a 
constituency, informing policy makers, maintaining momentum, 
recovering from setbacks, negotiation, celebrating success and 
ongoing advocacy.(52)  
Health education:  
Since STI, HIV are diseases that are strongly related to 
behaviour, health education will remain a cornerstone in the 
prevention and management. In fact, considerable resources were 
devoted to prevention through health education but practically there 
was little evidence that it affected sexual behaviours in the 
developing countries.  
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Denial and Moralization among common people were major 
obstacles in assessing one’s risk from the disease. As only weapon 
against HIV/AIDS, awareness should lead to behaviour change 
among the population.(53)   
A report on the AIDS epidemic in the African continent 
concluded that active government programs and strong Islam 
influence had resulted in a minimal incidence of HIV transmission in 
Western Africa.(54) 
So our Islamic religion could be incorporated in the active 
health education programs against STI.  
Condoms promotion: 
A study in a South African mining community saw a 30% 
reduction in overall STI prevalence as the miners increased their 
prevalence of condom use from 13% to 29%.(55) Furthermore, 
condoms promotion through social marketing had shown some 
successes e.g. in Ethiopia.(56) and Thailand. (57,58) 
It is important that resources for STI control should be 
concentrated on individuals at higher risk and that both sexes should 
be included; indeed it makes more sense to target men, who are 
perhaps at greater risk than their spouses and in whom the 
manifestations of STI are easier to recognize.(59)  
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Targeted programmes aimed at modifying the sexual 
behaviour of men and women through peer-education, increasing 
condom use and providing STI services near the work place have 
demonstrated their acceptability and effectiveness in reducing 
STI/HIV incidence among distance tracks drivers, factory workers 
and prostitutes in Eastern and Southern Africa.(60,61)  
Partner notification:  
Some people with symptom-less STI may be detected and 
treated through partner notification. Screening programmes that rely 
on laboratory test should be used. On the other hand in certain 
population with high prevalence of symptomless STI, the potential 
impact of targeted presumptive antibiotic treatment has been 
demonstrated.  
Finally there are many areas where more research and work 
are required in both low prevalence and high prevalence areas and 
would be greatly simplified with the development and distribution of 
low cost, effective and simple-used diagnostic tests for common STI. 
These tests should be able to identify symptoms-less patients.  
Researches should continue on the development of 
affordable and effective vaccine against STI. (62)  
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OBJECTIVES 
 
1- To determine the prevalence of the common STIs and 
candidiasis in women attending Omdurman Teaching Hospital 
and Police Central Hospital, Gynaecological Clinics. 
2- To evaluate the sensitivity and specificity of vaginal discharge 
as a diagnostic tool for some STIs. 
3-  To suggest a suitable line of management of STIs. 
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MATERIAL & METHODS 
1- Settings and duration: 
This study was carried out In Omdurman Teaching Hospital 
and police Central Hospital in the Gynecological referred clinics in 
the period from August 1999 to February 2000.  
2- Population: 
Khartoum is the capital of Sudan with estimated population 
of 4.6 millions according to the last national census; they represent 
different ethnic and racial groups. These two hospitals were selected 
because they are central referral clinics that are accessible to many 
people and attended by different socioeconomic classes. 
A total number of one hundred and ten non-pregnant 
females attending gynecological clinics for various reasons were 
selected randomly (1 in 4). Informed consent was taken from each 
patient before sample collection. 
3- Inclusion criteria:  
All ladies attending the gynecological clinics. 
 4- Exclusion criteria: 
a. Virgin ladies. 
b. Pregnant ladies. 
c. Ladies who are menstruating at the time of sample collection. 
d. Ladies who had taken any antibiotics within the last three weeks. 
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5- Data collection: 
The data was collected through:       
1- Interviewed administered questionnaire. 
2- Clinical examination. 
3- Laboratory tests. 
The questionnaire included questions on the age, 
occupation and husbands’ occupation, number of children and 
presence of vaginal discharge, its colour, amount, odour and other 
related symptoms. 
Clinical examination and laboratory tests:   
The examinations were conducted at the gynecological 
clinic, following informed consent, which included a thorough 
general examination followed by genital examination. Through 
bivalve speculum, cervical swabs were taken followed by 5 ml of 
venous blood.   
Sample size:     
We obtained 220 endo-cervical swabs, 110 of them for 
culture to isolate and identify N. gonorrhea and then for detection of 
Chlamydial antigen. Also we obtained 110 high vaginal swabs for 
wet preparation to detect T. vaginalis and for Gram stain to detect 
C.albicans. From each patient we took 5.0 ml of venous blood for 
serology of HIV and Syphilis. 
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Collection of specimens:   
1- Endocervical swabs:   
From each patient enrolled in the study, a doctor using the 
following steps collected two endocervical swabs. 
Exocervical area was cleaned with sterile gauze before 
sampling process, to remove excess of mucus then the cotton swab 
was inserted into cervical canal and rotated vigorously for 5-10 
seconds, and inserted as soon as possible into QUORUM EIA 
chlamydia Ag transport medium. Enzyme-immunoassay for the 
detection of chlamydia is then performed. 
 2 -High Vaginal swabs (HVS):  
A doctor by using sterile speculum with sterile cotton swab 
collected HVS from each patient and immediately the swabs were 
inoculated either into sterile physiological saline or Amies transport 
medium so as to perform the microbiological examinations. 
3- Venous Blood:   
We obtained 5 ml venous blood from each patient attending 
previous clinics by using vacutainer tube. The sera was then 
separated and stored at -20°C freezer so as to perform certain 
immunoserological tests for both syphilis and HIV.  
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I- Microbiological methods:  
  Microscopical examination:        
• Wet preparation:-  
Specimens of HVS as collected above were examined by 
wet preparation method. A drop of physiological saline (10%koh) 
covered by a cover slip, then HVS was squeezed on the slide and 
examined microscopically, for motile T. vaginalis and Candida spp. 
using10x and 40x. 
• Gram stain:- 
 Specimen of HVS collected as previously described were 
also examined by Gram stain .The smears from the swabs should 
be fixed on slide using 70% of ethanol, then stained with Gram stain 
to detect if Gram positive yeast cells present or not.  
Also specimens of endocervical swabs as previously 
described were examined by Gram stain techniques to detect if 
gram-negative diplococci within polymorph nuclear leukocytes 
present or not. 
II- Culture methods:  
Culture of HVS on Sabouraud dextrose agar:   
Specimens of HVS were inoculated into Sabouraud 
dextrose media agar under aseptic technique, and incubated at             
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35- 36ºC for two days. The evidence growth of Candida indicated by 
white to creamy colonies, characterized by yeast smell. Then the 
growth colonies were examined by direct microscopy using either 
stained or unstained smear techniques. In addition, Identification of 
C. albicans was confirmed by the Germ tube test (GTT). Colonies 
suspected Candida albicans were emulsified into small tube 
containing about 0.1 ml of sterile human serum and incubated at 
36ºC in water bath for 2-3 hours (Kafi 1997) then examined for germ 
tube outgrowth that form yeast cells. 
III-Serological methods:   
1- QUORUM EIA CHLAMYDIA:    
• Principle of the Assay:  
Coated microtitration wells are used as the solid phase 
media. Chlamydiae are boiled to solubilize chlamydia (LPS). The 
solubilized chlamydia (LPS) test samples are applied to the wells 
and incubated. After incubation, monoclonal antibody reagent is 
added to each well and incubated. This reagent will bind to any 
chlamydia LPS present wells. After washing, an anti- mouse lgG 
antibody with Horseradish Peroxidase enzyme (conjugate), is added 
After a 30 minutes incubation at 37ºc, the wells are washed to 
remove unbound labeled antibodies. On addition of the substrate 
(TMB) a colour will develop only in those wells in which enzyme is 
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present, indicating the presence of chlamydia. The reaction by the 
addition of stop solution and the absorbance is then measured at 
450 nm. The cut- off value is calculated and the samples with 
absorbents greater than the cut-off are considered positive. 
h Assay procedure:  
1- Preheat a humidity box to 37ºC.  
2- Prepare a Data Sheet to identify the individual wells for each 
sample and control. It is recommended to run one set of 
standards in each sample run. Unused strips should be resealed 
in the foil bag, containing the desiccant, using the resealing zip-
lock before being replaced. 
3- Pipette 100µI of prepared specimens and positive and negative 
controls into their assigned wells. Include one positive and 2 
negatives in each assay run. 
4- Incubate for 30 minutes at 37ºC in the humidity box. 
5- Remove the plate from the humidity box replacing the humidity 
box at 37º C to maintain temperature. 
6- Add 100µl of monoclonal antibody reagent to each well. Tab 
gently for 5 seconds to ensure mixing the volume in each well 
will now be 200µL. 
7- Incubate for 30 minutes at 37ºC in the humidity box. 
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8- At the end of the incubation period remove the plate from the 
humidity box and return the box to 37ºC. Discard the contents of 
the well by turning the plate rapidly upside down over a 
Biohazard container. Then strike the plate (still upside down) 
against absorbent paper or paper towel. Ensure adequate 
disinfectant is contained in the Biohazard container. 
9- Wash the empty wells 4 times with the diluted Wash Buffer .The 
direction of filling the plate in each cycle must by alternated; i.e. if 
the plate is filled top to bottom for the first wash; fill from bottom 
to top for the second wash. 
10- Strike the wells sharply onto absorbent paper towel to remove all 
the residual water. 
11- Add 100µl of Anti- Mouse Peroxidase to each well and incubate 
for 30 minutes at 37ºC in the humidity box. 
12- Add 100 µl of TMB Substrate to well and gently mix for 5 
seconds. 
13- Incubate at room temperature (20°C - 25°C) for 10 minutes in 
the dark. 
14- Stop the reaction by adding 100 µl of stop solution to each well. 
15- Gently mix for 30 seconds to ensure that the blue colour 
changes completely to a yellow colour. 
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16- Immediately read the optical density at 450nm with a microtitre 
plate reader blanked on air. 
2- Serological diagnosis of syphilis: 
We tested all sera of the patients for syphilis using Rapid 
Plasma Reagin (RPR), those who are tested positive are retested 
using the specific treponemal test (TPHA) for confirmation of 
syphilis.   
I- IMMUNTREP-RPR:  
Immuntrep-RPR is a non-treponemal Rapid Plasma 
Reagent flocculation test for syphilis reagent antibodies in serum or 
plasma. It is a modified form of IMMUTREP-VDRL ANTIGEN which 
contains carbon particles to improve the visual reading of the result. 
The use of the carbon opiates the requirement for a microscope 
when recording the test results. The test can be performed on 
heated, unheated serum or plasma and is therefore very versatile. 
The test Kit is complete in that it provides test cards pipette/stirrers, 
antigen dispensers and positive and negative controls. 
II- Treponema pallidum Haemoagglutination assay (TPHA) 
(Wellcosyph HA) 
 Wellcosyph HA is a rapid assay for in vitro specific 
antibodies to T. pallidium in human serum by indirect 
haemoagglutination (IHA) method. Preserved avian erythrocytes are 
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coated with antigen components of pathogenic T. pallidium (Nicols 
strain). These cells agglutinate in the presence of specific antibodies 
to T. pallidium and show characteristic in microtitration plates. 
Procedure:-  
Each test requires 4 well of microtitration plate: - 
1-  25 µL of Diluent’s buffer containing 0.1 %sodium azide were 
added to each of 1,3,4 while 100µL were added to well 2. 
2-  25 µL of patient serum was added to well 1 by using 
micropipette. 
3- Using micropipette the contents of well 1 were mixed 25µL were 
transferred to well 3. Well 3 was mixed and 25µLfrom well 2 was 
transferred to well 4.Well 4 was mixed and 25µL was discarded. 
4-  Two further pairs of wells are required for the positive and 
negative controls. 
5-  The Test and Control cells were re-suspended. 75µLof Control 
cells were added to well 3 while, 75µL of test cell was added to 
well 4. Tapping all four sides of plate mixed contents of the 
plates. The plate was incubated at room temperature for 45- 60 
minutes. 
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Reading of results:  
Positive results:   
A strong positive result will appear as smooth material at 
test cells on the bottom of the well, some times with folded edge. 
With less strongly reacting sample this material will be smaller and 
may be surrounded by a circle of cells. 
Negative results:   
 A negative result is indicated by a compact bottom of non-
agglutination test cells without a very small hole in the centre. 
3- Biotest anti HIV-1-2 recombinant (ELISA):  
The biotest anti HIV-1-2 recombinant is very sensitive solid 
phase enzyme immunoassay in which highly purified recombinant 
viral antigens are used for the combined detection of anti bodies to 
HIV-1 and HIV-2.  
The immuno-dominant-N-terminal parts of the 
transmembrane proteins gp41 and gp 35 of HIV-1 and HIV-2 as well 
as the highly reactive core antigen p24 of HIV are produced from the 
bacteria (E. coli) by means of recombinant technology; these 
antigens are highly purified and used for coating microtest plate.  
During serum incubation HIV specific antibodies bind to the 
recombinant viral antigens.  
  41 
Unspecific antibodies are removed by subsequent washing 
step. The antigen-antibody complexes formed during first incubation 
steps are detected with highly specific enzyme labeled monocolonal 
antibodies directed against human IgG.  
The enzyme activity of the bound conjugate is then 
determined. The reaction is stopped using H2SO4.        
Procedure:  
• Using a micropipette, with disposable tips, 50 µl of test serum 
were added, each into a microwell.  
• 50 µL of the negative control serum were added into three 
microwells.  
• 50 µL of the cut-off control serum were added into two 
microwells. 
• 50 µL of positive control serum were added into one microwell. 
• 75 µL of working strength conjugate were added to all microwells 
using a multichannel micropipette.  
• Plates were covered and incubated in a water-path at 37°C for 
one hour.  
• After the period of incubation the plates were washed as 
described by the manufacturer.  
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•  100 µL of the pink coloured substrate solution were added to 
each microwell and the plated were covered and incubated at 
37°C for 20 minutes.  
• 100 µL of the stop solution (2M sulphuric acid) were added to 
each microwell and the plates were read within 30 minutes using 
a microwell plate reader. 
The presence or absence of antibodies to HIV-1-2 is 
determined in relation to the mean absorbance of the cut-off control 
serum. Samples with absorbance readings equal to or less than the 
mean absorbance of the cut-off control serum are considered as 
reactive for antibodies to HIV-1-2. Absorbance readings of the 
negative and positive control samples are used to determine the 
validity of the test results.   
  
 
 
 
 
 
 
 
 
  43 
RESULTS 
Table 1 shows the distribution of the studied population 
according to the age. Most of the cases (39.1%) aged between 26-
35 years.  
Table 2 shows that most of the cases are multiparous 
(60.9%), while nulliparous accounted for 22.7% and primiparous 
accounted for only 16.4%.  
Table 3 shows that most of the studied populations are 
housewives (80.9%). 
Table 4 shows that, 27.3% were married to policemen, 
14.5% to labourers, 10% to employees, 8.2% to drivers and 40% to 
those with other occupations.   
Table 5 shows the prevalence of STI and candida in the 
studied population, as follows: Chlamydial infection (9.1%), candidal 
infection (19.1%), Trichomoniasis (6.4%), gonoccal infection (1.8%), 
confirmed syphilis (5.4%) and HIV (1.8%).  
Tables 6 & 7 show that the overall prevalence of STI was 
38.2%, while the prevalence of more than one STI is 4.5%.  
Table 8 shows that the prevalence of vaginal discharge in 
the studied population is 83.6%.  
Table 9 shows the prevalence of vaginal discharge 
according to its colour. White curdy discharge account for 72.8% of 
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those with vaginal discharge, yellowish vaginal discharge found in 
14.1% and greenish vaginal discharge in only 3.3%. 9.8% of the 
vaginal discharge was a clear one.  
Table 10 shows that yellowish vaginal discharge is neither 
sensitive nor specific for diagnosis of chlamydial infection with 
sensitivity and specificity of 20% and 89% respectively.  
Table 11 shows that greenish vaginal discharge is not good 
predictor of trichomoniasis with positive predictive value of 33.3%. 
However, it has a good specificity (98.1%).  
Table 12 shows that white vaginal discharge has poor 
positive and negative predictive values (20.9%) and (80.6%) 
respectively for the diagnosis of candidal infection.  
Table 13 shows that, 50.5% of those with vaginal discharge 
had copious discharge and 49.5% had slight discharge.  
Table 14 shows that the sensitivity of the presence of 
copious vaginal discharge for the diagnosis of trichomoniasis was 
57.1% and its specificity was 50%.  
Table 15 shows that the sensitivity of copious vaginal 
discharge for the diagnosis of chlamydial infection (66.7%), while its 
specificity was 52.4%.  
Table 16 shows that offensive vaginal discharge has a 
sensitivity of 42.9% for the diagnosis of trichomoniasis.  
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Table 17 shows that the prevalence of genital ulcer as         
a complain in the studied population was 6.4%.  
Table 18 shows that the presence of genital ulcer on 
examination of the studied population has a sensitivity of 16.7%.  
Tables 19 & 20 show that the husband’s occupation does 
not significantly increase the risk or trichomoniasis or chlamydial 
infection.  
Table 21 shows that the prevalence of some related STI 
symptoms as follow; burning micturition (58.2%), womb pain 
(66.4%) and pain during sexual intercourse (50.9%).  
Table 22 shows the prevalence of pelvic tenderness during 
examination in the studied population was 26.4%.  
Table 23 shows that the prevalence of some examination 
findings in the studied population; 25.7% had abdominal tenderness, 
2.7% had vesicles on the genitalia, 85.5% had vaginal discharge, 
30% had a discharge from the cervix, 7.3% had ulcers on the cervix 
and cervical excitation sign was found in 5.6%. There were no cases 
of genital warts, skin rash or generalized lymphadenopathy.  
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Table 1: 
Distribution of studied population according to age  
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Range (in years) No. of patients % 
18 – 25 35 31.8 
26 – 35 43 39.1 
> 35 32 29.1 
Total  110 100 
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Table 2: 
Distribution of studied population according to parity 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Parity  No. of patients % 
Nulliparous 25 22.7 
Primiparous 18 16.4 
Multiparous 67 60.9 
Total  110 100 
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Table 3: 
Distribution of studied population according to occupation 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Occupation No. of patients % 
Housewives 89 80.9 
Students 04 3.6 
Employee 01 0.9 
Others 16 14.5 
Total  110 100 
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Table 4: 
Distribution of studied population according to husband’s 
occupation (O.T.H and P.C.H Gynaecological clinics,  
Aug. 1999-Feb. 2000) 
Husband Occupation No. of patients % 
Employees 11 10.0 
Policemen 30 27.3 
Labourers  16 14.5 
Drivers 09 8.2 
Others 44 40.0 
Total  110 100 
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Table 5: 
Prevalence of different STIs and candida in the studied 
population (O.T.H and P.C.H Gynaecological clinics,  
Aug. 1999-Feb. 2000) 
STI No. of patients % 
Chlamydia trachomatis  10 9.1 
Candida albicans 21 19.1 
Trichomonas vaginalis 07 6.4 
N. gonorrhea  02 1.8 
Syphilis:  
- RPR 
- TPHA 
 
12 
06 
 
10.9 
5.4 
HIV 02 1.8 
Total  48  
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Table 6: 
Overall prevalence of STI in the studied population  
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
STI No. of patients % 
Had at least one STI or candidiasis 42 38.2 
Had no STI or candidiasis  68 61.2 
Total  110 100 
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Table 7: 
Prevalence of more than one STI in the studied population 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
No. of STI No. of patients % 
Had one STI            37 33.6 
Had two STI 05 4.5 
Had three STI 0 0 
Total  42  
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Table 8: 
Prevalence of vaginal discharge in the studied population 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Vaginal discharge No. of patients % 
Had vaginal discharge         92 83.6 
Had no vaginal discharge    18 16.4 
Total  110 100 
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Table 9: 
Distribution of vaginal discharge according to its colour  
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Colour of the discharge No. of patients % 
White-curdy               67 72.8 
Yellowish 13 14.1 
Greenish 03 3.3 
Clear 09 9.8 
Total  92 100 
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Table 10: 
Sensitivity and specificity of a yellowish vaginal discharge for 
diagnosis of chlamydia (P = NS) 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
                        Chlamydia 
Yellow discharge 
Positive chamydia 
  
No chlamydia
  
Total 
Yellow vaginal discharge 2          
(15.4%) 
(20%) 
11       
(84.6%) 
(11%) 
13 
No yellow vaginal discharge 8         
 (25.8%) 
(80.0%) 
89       
 (74.2%) 
(89%) 
97 
Total  10 100 110 
 
- Sensitivity: 20%.  
- Specificity: 89%. 
- Positive predictive value: 15.4%.  
- Negative predictive value: 74.2%.  
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Table 11: 
Sensitivity and specificity of greenish vaginal discharge for 
diagnosis of Trichomoniasis (P=NS) 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
                  Trichomonaisis 
Greenish discharge 
Positive 
Trichomoniasis 
No 
Trichomoniasis 
Total 
Green vaginal discharge 1         
 (33.3%) 
(16.7%) 
2        
(66.7%) 
(1.9%) 
3 
No green vaginal discharge 6          
(5.6%) 
(83.3%) 
101      
  (94.4%) 
(98.1%) 
107 
Total        7     103 110 
 
- Sensitivity: 16.7%.  
- Specificity: 98.1%. 
- Positive predictive value: 83.3%.  
- Negative predictive value: 94.4%.  
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Table 12: 
Sensitivity and specificity of a white vaginal discharge for 
diagnosis of candida (P=NS) 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
                  Candida 
Witish discharge 
Positive 
Candida 
No 
Candida 
Total 
With vaginal discharge 14          
(20.9%) 
(66.7%) 
53       
 (79.1%) 
(59.5%) 
67 
No vaginal discharge 7          
(19.4%) 
(33.3%) 
36     
   (80.6%) 
(40.5%) 
43 
Total        7     103 110 
 
- Sensitivity: 16.7%.  
- Specificity: 40.5%. 
- Positive predictive value: 20.9%.  
- Negative predictive value: 80.9%.  
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Table 13: 
Amount of discharge in those with vaginal discharge    
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Amount of discharge  No. of patients % 
Copious discharge 46 50.5 
Slight discharge 45 49.5 
Total  91* 100 
 
* in one patient the amount of the vaginal discharge is not mentioned.  
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Table 14: 
Relation of copious vaginal discharge for diagnosis and 
trichomoniasis infection (P=NS) 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
                  Copious 
Trichomoniasis 
Positive 
trichomoniasis 
Negative 
trichomoniasis 
Total 
Copious discharge 04          
(8.7%) 
(57.1%) 
42       
 (91.3%) 
(50%) 
46 
Slight discharge 03          
(6.7%) 
(42.9%) 
42       
 (93.3%) 
(50%) 
45 
Total  7 84 91 
 
- Sensitivity: 57.1%.  
- Specificity: 50.0%. 
- Positive predictive value: 8.7%.  
- Negative predictive value: 93.3%.  
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Table 15: 
Relation of copious vaginal discharge and chlamydial infection   
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
                          Copious 
 
Chlamydial infection  
Positive 
chlamydial 
infection  
Negative 
chlamydial 
Infection  
Total No. 
of 
patients 
Yes 06          39        45 
No 03          43        46 
Total  9 82 91 
 
- Sensitivity: 66.7%.  
- Specificity: 52.4%. 
- Positive predictive value: 13.3%.  
- Negative predictive value: 93.5%.  
 
 
 
 
 
 
 
  61 
 
Table 16: 
Relation between offensive vaginal discharge on examination 
and trichomoniasis   
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
                  Trichomoniasis 
Vaginal discharge 
Positive 
trichomoniasis 
Negative 
trichomoniasis
Total 
Offensive 03         
 (10.3%) 
(42.9%) 
26     
  (89.7%) 
(25.2%) 
29 
Not offensive 04          
 (4.9%) 
(57.1%) 
77      
  (95.1%) 
(74.8%) 
81 
Total  7 103 110 
 
- Sensitivity: 42.9%.  
- Specificity: 74.8%. 
- Positive predictive value: 10.3%.  
- Negative predictive value: 95.1%.  
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Table 17: 
Prevalence of genital ulcer on history    
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Genital ulcer No. of patients % 
Yes 7 6.4 
No 103 93.6 
Total  110 100 
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Table 18: 
Genital ulcer as a predictor of syphilis    
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Genital ulcer Positive syphilis Negative syphilis Total 
Positive history 01 0 01 
Negative history 05 104 109 
Total  06 104 110 
 
- Sensitivity: 16.7%  
- Specificity: 0.0%   
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Table 19: 
Relation of husband’s occupation and chlamydial infection  
(P. value = 0.69036843)    
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999- Feb. 2000) 
           Chlamydial infection
 
Husband occupation 
Positive 
chlamydial 
Negative 
chlamydial 
Total 
Employee 1   
(9.1%) 
10.0% 
10   
(90.9%) 
10.0% 
11 
Policeman 2  
(6.7%) 
20.0% 
28   
(93.3%) 
28.0% 
30 
Labourer 1  
(6.3%) 
10.0% 
15  
 (93.8%) 
15.0% 
16 
Drivers 2  
(22.2%) 
20.0% 
07   
(77.8%) 
7.0% 
9 
Others 4 
 (9.1%) 
40.0% 
40   
(90.9%) 
40.0% 
44 
Total  10  
(9.1%) 
100  
(90.9%) 
110 
- Chi square: 2.25.  
- Degree of freedom = 4. 
- P. value = 0.69036843.   
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Table 20: 
Relation of husband’s occupation and Trichomonas infection 
(P. value = 0.69036843)    
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
       Trichomonas infection 
 
Husband occupation 
Positive 
Trichomonas 
Negative 
Trichomonas 
Total 
Employee 0 
 (0.0%) 
0.0% 
11 
(100%) 
10.7% 
11 
Policeman 1  
(3.3%) 
14.3% 
28  
 (96.7%) 
28.2% 
30 
Labourer 2 
 (12.5%) 
28.6% 
14  
 (87.5%) 
13.6% 
16 
Drivers 1  
(11.1%) 
14.3% 
8 
  (88.9%) 
7.8% 
9 
Others 3 
 (6.8%) 
42.9% 
41  
 (93.2%) 
39.8% 
44 
Total  7 
 (6.4%) 
103 
(93.6%) 
110 
 
- Chi square: 2.58.  
- Degree of freedom = 4. 
- P. value = 0.63096176.  
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Table 21: 
Prevalence of some related symptoms in studied population 
and their duration 
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Symptoms No. of patients % Duration 
   < 1 month ≥ 1 month
Burning mictrition  64 58.2 71% 29% 
Womb pain 73 66.4% 52.8% 47.2% 
Pain during sexual 
intercourse  
56 50.9% 30.9 69.1% 
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Table 22: 
Prevalence of pelvic tenderness on examination of the studied 
populations   (O.T.H and P.C.H Gynaecological clinics,  
Aug. 1999-Feb. 2000) 
Pelvic tenderness No. of patients % 
Yes 29 26.4 
No 81 73.6 
Total  110 100 
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Table 23: 
Prevalence of some examination findings in the studied 
population    
(O.T.H and P.C.H Gynaecological clinics, Aug. 1999-Feb. 2000) 
Examination findings No. of cases % 
Generalized lymphadenopathy 0 0 
Skin rash 0 0 
Abdominal tenderness 28 25.7 
Vesicles on the genitalia 03 2.7 
Vaginal discharge 94 83.6 
Discharge from the cervix 33 30.0 
Ulcer on the cervix 08 7.3 
Genital warts 0 0 
Cervical excitation sign 6 5.6 
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DISCUSSION  
Sexually transmitted infections are common problem in the 
developed and developing countries. We randomly studied 110 
women of those who attended the Gynaecological Clinics in 
Omdurman Teaching Hospital and police central Hospital in the 
period from August 1999 to February 2000. 
The range of most the studied population (39.1%) was 
between 26-35 years, while 31.8% were between 18-25 years. 
Multiparous ladies account for 60.9% of cases, nulliparous 22.7% 
while primiparous accounted for only 16.4%. 
The majority of cases were housewife’s 80.9%, while 27.3% 
of the husbands work as policemen. This is because the police 
central hospital is the main referral hospital for other police health 
centres. On the other hand it provides free services to all police 
forces.  
The prevalence of Candida albicans in this study was 
19.1%. In fact, candida is not a STI but it is mentioned here because 
it is the commonest organism that causes vaginal discharge. This 
prevalence is low compared to other African countries e.g. South 
Africa in which Ramjee(32) found that the prevalence was 40.6% 
compared to Cohen(38) who found that the prevalence in Indonesia 
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was 44%, the prevalence in our study seems to be lower than other 
parts of the world. 
El haj(19) found a prevalence of 9.1% in a non-pregnant 
population in a rural Sudanese community; while Ortashi (46) found a  
prevalence of 13.9% in pregnant Sudanese patients. 
The prevalence of Chlamydia was 9.1%.  This prevalence 
goes with the study of Cohen(38) in Indonesia who found the 
prevalence was 7.7%. It may be lower than other parts of the world 
like South Africa (32) and. Cameroon.(31) 
Ortashi(46) found a relatively higher prevalence which was 
19.9%. In fact, It was the highest written in the literature concerning 
Africa and Islamic world. 
The prevalence of Trichomoniasis was 6.4%, which is a low 
prevalence compared with the literature(33, 25) where the prevalence 
was 23.8% and 25.3% respectively, this may reflect the conservative 
sexual behavior in our studied population. 
The low prevalence of N. gonorrhea in this study 1.8% goes 
with other studies,(25,46) which found a prevalence of 2% both. This 
low prevalence may be due to widely use of antibiotics against 
gonococcal infection by the general population. 
Using R.P.R for the diagnosis of syphilis a prevalence of 
10.9% was found. This dropped to 5.4% when the results were 
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rechecked using TPHA. This highlights the significance of false 
positive results when using non-specific test for the diagnosis of 
syphilis. This prevalence is a little pit higher than the literature (27,36) 
who mentioned prevalence of 4% both. Ortashi (46) found a lower 
prevalence, which was 2.6%.  
HIV infection was detected in 1.8% of the studied 
population. Renganathan in Egypt (40) found a similar prevalence of 
1.5%. Other literature(16)mentioned a prevalence of 0.6% in Sudan. 
This was in contrast to Ortashi (46) who did not detect any case of 
HIV in his study. This low prevalence is mainly due to cultural and 
religious factors in the studied population. 
The overall prevalence of STI was 38.2%, while the 
prevalence of two STI was 4.5%. None of the studied population had 
more than two STI, so multiple infections is not common.  
The prevalence of vaginal discharge was 83.6%, which is a 
high prevalence. This may be due to the fact that the question about 
vaginal discharge was not specific. In fact ladies were asked about 
the presence of vaginal discharge. The question in the questionnaire 
should have been about abnormal vaginal discharge. This 
prevalence is high compared to the literature (25, 46) which mentioned 
a prevalence of 77% and 55.6% respectively. 
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The colour of the discharge was white curdy in 72.8%, 
yellow in 14.1%, greenish in 3.3% and clear in 9.8%. The colour of 
the discharge was found neither sensitive nor specific for the 
diagnosis of Chlamydia (sensitivity 20% and specificity 89%). The 
sensitivity of greenish vaginal discharge for Trichomonias infection is 
low 16.7%, however it has a good specificity 98.1%. 
White vaginal discharge has poor positive and negative 
predictive values (20.9% and 80.6% respectively) for the diagnosis 
of Candida infection. 
These results reflect the difficulty of predicting the aetiology 
of vaginal discharge from its colour. In fact this is one of the major 
problems that face the syndromic approach. 
Copious vaginal discharge was prevalent in 50.5% of cases 
of vaginal discharge. Nevertheless, it was not sensitive nor specific 
for the diagnosis of Chlamydia or Trichomoniasis. 
Offensive vaginal discharge has a very low sensitivity and 
specificity for the diagnosis of Trichomonaisis (42.9% and 74.8% 
respectively). 
The presence of genital lacer as a complain was 6.4% but 
this was not significant for the diagnosis of syphilis. Moreover, the 
presence of genital ulcer was not found to be specific or sensitive for 
the diagnosis of syphilis. 
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We found that the husband’s occupation does not increase 
the risk of trichomonas or chlamydial infection. 
The prevalence of some related symptoms of STI were, 
burring micturition (58.2%), womb pain (66.4%) and pain during 
sexual intercourse (50.9%). 
The prevalence of some examination findings were pelvic 
tenderness (26.4%), abdominal tenderness (25.7%), vesicles on the 
genitalia (2.7%), vaginal discharge (85.5%), discharge from the 
cervix (30%), ulcer on the cervix (7.3%) and cervical excitation sign 
was found in (5.6%). 
There were no cases of genital warts, skin rash or 
generalized lymphadenopathy.  
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CONCLUSION 
 
• The prevalence of sexually transmitted infections in the studied 
population is high (38.2%). 
• Vaginal discharge is a very common complains with a prevalence 
of 83.6%. 
• Clinical diagnosis is not an accurate predictor of infection at the 
individual level.  
• If the syndromic approach (vaginal discharge syndrome) is 
applied a lot of cases will be over treated. Many cases will also 
be missed.  
• The high prevalence of STI detected in this study suggests that 
HIV infection will spread rapidly in the community unless specific 
measures are taken.   
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RECOMMENDATIONS 
 
• All patients with vaginal discharge should be assessed further for 
STI. 
• Simple, specific and cost-effective tests for STI should be 
introduced so as to adopt the aetiological approach in the 
management of STI. 
• Health education remains the corner stone in the prevention of 
STI/HIV. 
• All patients with confirmed STI should receive health education 
about HIV.  
• Identification of population at the greatest attributable risk for HIV, 
which will facilitate targeted control efforts.  
• S TI clinics should be established.  
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INTERVIEW AND EXAMINATION 
 
A. Interview 
1. Study Number 
2. Date                                Day                 Month                 Year 
3. Clinic name                              ……………………………………………………………………… 
4. Clinic number 
 
History 
5. Age                                                                                                         years 
6. Number of children 
7. Occupation                                     ………………………………….…………………. 
8. Parent's occupation                        ………………………………….…………………. 
 
Symptoms 
9. Do you have a genital ulcer                                                  Yes          No            
   If "no" skip to 13 
  If "yes" 
10. Is it painful                                                                          Yes          No            
11.How long have you had the genital ulcer                      days 
12.Do you have a vagina discharge                                         Yes          No            
     If "no" skip to 13 
     If "yes" 
13. What is the colour of the discharge?   …………………………..……………….………              
14. Is it foul smelling?                                                                  Yes         No            
15.  Is it slight or copious?                                                  Slight          Copious 
16. How long have you had the discharge?                              days 
17. Do you have a burning sensation when you have pass urine?  Yes         No 
If "no" skip to 20 
If "yes" 
18. How long have you had the burning sensation?                               days 
19. Do you have pain in your womb                                    Yes             No 
If "no" skip to 22 
If "yes" 
20. How long have you had the womb pain?                               days 
21. Do you have pain during sexual intercourse?                      Yes          No            
     If "no" skip to 24 
     If "yes" 
22. How long have you had pain during sexual intercourse?                          days 
23. Do you have swelling in the groin?                                      Yes          No            
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     If "no" skip to 27 
     If "yes" 
24. It is painful?                                                                          Yes          No            
25. How long have you had groin swelling?                                            days 
26. In the past have you had any of the following?                                  
27a. Vaginal discharge                                                         Yes          No 
27b. Sores on the genital area                                             Yes          No            
27c. Pain deep down in the lower part of your abdomen     Yes          No            
27d. Vaginal discharge                                                         Yes          No            
27a. Painful swelling in the groin                                          Yes          No 
A. Examination:             
     Are any of the following present:  
1. Generalized lymphadenopathy                                               Yes          No 
2. Shin rash                                                                                Yes          No            
3. Abdominal tenderness                                                           Yes          No            
4. Abdominal mass                                                                    Yes          No            
5. Pelvic tenderness                                                                   Yes          No            
6. Inguinal bubo                                                                          Yes          No            
7. Genital ulcers                                                                         Yes          No            
8. Vesicles on the genitals                                                         Yes          No           9. Vaginal 
discharge          None            Clear             Curdy             Yellow                             
  
10. Foul smelling vaginal discharge                                           Yes          No            
11. Discharge from the cervix                                                    Yes          No            
12. Ulcers on the cervix                                                             Yes          No            
13. Genital warts                                                                        Yes          No            
14. Cervical excitation tenderness                                             Yes          No            
15. Height of uterine fundus                                                                       weeks               
Gynaecological diagnosis: …………………………………………………………… 
 
Results of tests:  
1. Study Number                                                        
2. Clinic name     ………………………………………………………………………………………                                                
3. Clinic number              
4. Date specimens received               day                 month                   year            
5. Date report sent out                       day                 month                   year            
 
A. Height of vaginal smear: …………………………………………………………… 
Candida                                                       Pos                  Neg   
Gardnerella                                                  Pos                  Neg            
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B. Wet mount:   
Trichonomas                                                Pos                  Neg   
C. Gonococcal culture: 
N. gonorrhoeae                                            Pos                  Neg   
PPNG stains                                                 Pos                  Neg  
Isolated stains of N. gonorrhoeae are sensitive to the following antibiotics:  
………………………………………………………………………………….…………………………………………….           
        
Isolated stains of N. gonorrhoeae are resistant to the following antibiotics:  
………………………………………………………………………………….…………………………………………….           
D. Haemophilus ducreyi culture: 
H. ducreyi culture                                          Pos                  Neg   
 Isolated stains of H. ducreyi are sensitive to the following antibiotics:  
………………………………………………………………………………….…………………………………………….           
        
Isolated stains of H. ducreyi are resistant to the following antibiotics:  
………………………………………………………………………………….…………………………………………….           
E. Chlamydia antigen test: 
Chlamydia ELISA test                                  Pos                  Neg   
F. Herpes virus antibody test: 
Herpes simplex virus Type I antibody           Pos                  Neg   
Herpes simplex virus Type II antibody          Pos                  Neg   
G. HIV test: 
ELISA I                                                          Pos                  Neg   
ELISA                                                            Pos                  Neg   
H. Syphilis: 
RPR                                                              Pos                  Neg   
TPHA                                                            Pos                  Neg   
 
 
